Oral Candidiasis - Medicine bibliographies - in Harvard style

In-text: (Akpan and Morgan, 2002)

Your Bibliography: Akpan, A. and Morgan, R. (2002). Oral candidiasis. Postgraduate Medical Journal, 78(922), pp.455-459.

In-text: (Arendorf and Walker, 1980)

Your Bibliography: Arendorf, T. and Walker, D. (1980). The prevalence and intra-oral distribution of Candida albicans in man. Archives of Oral Biology, [online] 25(1). Available at: http://www.aobjournal.com/article/0003-9969(80)90147-8/abstract [Accessed 23 Apr. 2015].

In-text: (Calderone and Fonzi, 2001)

Your Bibliography: Calderone, R. and Fonzi, W. (2001). Virulence factors of Candida albicans. Trends in Microbiology, [online] 9(7). Available at: http://www.cell.com/trends/microbiology/abstract/S0966-842X(01)02094-7?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0966842X01020947%3Fshowall%3Dtrue [Accessed 23 Apr. 2015].

In-text: (Denning, 1997)

Your Bibliography: Denning, D. (1997). Echinocandins and pneumocandins--a new antifungal class with a novel mode of action. Journal of Antimicrobial Chemotherapy, [online] 40(5), p.611. Available at: http://jac.oxfordjournals.org/content/40/5/611.full.pdf [Accessed 22 Apr. 2015].

In-text: (Denning, 2002)

Your Bibliography: Denning, D. (2002). Echinocandins: a new class of antifungal. Journal of Antimicrobial Chemotherapy, 49(6), pp.889-891.

In-text: (Dewick, 2006)

Your Bibliography: Dewick, P. (2006). Essentials of organic chemistry. Chichester, West Sussex, England: J. Wiley, p.294.

In-text: (drugbank.ca, n.d.)

Your Bibliography: drugbank.ca (n.d.). Posaconazole. [online] Available at: http://www.drugbank.ca/drugs/DB01263#references [Accessed 21 Apr. 2015].

In-text: (Drugs.com, 2015)

Your Bibliography: Drugs.com (2015). Posaconazole Monograph for Professionals. [online] Drugs.com. Available at: http://www.drugs.com/monograph/posaconazole.html [Accessed 20 Apr. 2015].

In-text: (Gershkovich and Hoffman, 2007)

Your Bibliography: Gershkovich, A. and Hoffman, A. (2007). Effect of a high-fat meal on absorption and disposition of lipophilic compounds: the importance of degree of association with triglyceride-rich lip... - PubMed - NCBI. [online] Ncbi.nlm.nih.gov. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17604610 [Accessed 21 Apr. 2015].

In-text: (Groll and Walsh, 2005)

Your Bibliography: Groll, A. and Walsh, T. (2005). Posaconazole: clinical pharmacology and potential for management of fungal infections. Expert Review of Anti-infective Therapy, 3(4).

In-text: (Hof, 2006)

Your Bibliography: Hof, H. (2006). A new, broad-spectrum azole antifungal: posaconazole ? mechanisms of action and resistance, spectrum of activity. Mycoses, 49(s1), p.2.

In-text: (Jawetz et al, 1978)

Your Bibliography: Jawetz et al (1978). "Medical Mycology", Review of Medical Microbiology. 13th ed. pp.276-278.

In-text: (Krieter et al., 2004)

Your Bibliography: Krieter, P., Flannery, B., Musick, T., Gohdes, M., Martinho, M. and Courtney, R. (2004). Disposition of Posaconazole following Single-Dose Oral Administration in Healthy Subjects. Antimicrobial Agents and Chemotherapy, 48(9).

In-text: (Krishna et al., 2012)

Your Bibliography: Krishna, G., Ma, L., Prasad, P., Moton, A., Martinho, M. and O'Mara, E. (2012). Effect of posaconazole on the pharmacokinetics of simvastatin and midazolam in healthy volunteers. Expert Opinion on Drug Metabolism & Toxicology, 8(1).

In-text: (Krishna et al., 2009)

Your Bibliography: Krishna, G., Moton, A., Ma, L., Savant, I., Martinho, M., Seiberling, M. and McLeod, J. (2009). Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: A phase I, randomized, open-label, crossover study in healthy volunteers. Clinical Therapeutics, 31(2), pp.286-298.

In-text: (Krishna et al., 2009)

Your Bibliography: Krishna, G., Moton, A., Ma, L., Savant, I., Martinho, M., Seiberling, M. and McLeod, J. (2009). Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: A phase I, randomized, open-label, crossover study in healthy volunteers. Clinical Therapeutics, 31(2).

In-text: (Lipp, 2010)

Your Bibliography: Lipp, H. (2010). Clinical pharmacodynamics and pharmacokinetics of the antifungal extended-spectrum triazole posaconazole: an overview. British Journal of Clinical Pharmacology, 70(4).

In-text: (Medicines and Healthcare Products Regulatory Agency, 2015)

Your Bibliography: Medicines and Healthcare Products Regulatory Agency (2015). Black Triangle Scheme - new medicines and vaccines subject to EU-wide additional monitoring. 1st ed.

In-text: (Medicines and Healthcare Products Regulatory Agency, 2015)

Your Bibliography: Medicines and Healthcare Products Regulatory Agency (2015). Pharmacovigilance – how the MHRA monitors the safety of medicines. 1st ed. [ebook] Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/403099/Pharmacovigilance___how_the_MHRA_monitors_the_safety_of_medicines.pdf [Accessed 16 Apr. 2015].

In-text: (Medicines and Healthcare Products Regulatory Agency, 2015)

Your Bibliography: Medicines and Healthcare Products Regulatory Agency (2015). The Yellow Card Scheme: guidance for healthcare professionals - Detailed guidance - GOV.UK. [online] Gov.uk. Available at: https://www.gov.uk/the-yellow-card-scheme-guidance-for-healthcare-professionals [Accessed 16 Apr. 2015].

In-text: (Myers, 2006)

Your Bibliography: Myers, R. (2006). Immunizing and Antimicrobial Agents - Antifungal Agents. [online] Available at: http://courses.washington.edu/medch401/pdf_text/401_06_VI_Antifungal.pdf [Accessed 20 Apr. 2015].

In-text: (Pubchem.ncbi, 2015)

Your Bibliography: Pubchem.ncbi (2015). Posaconazole | C37H42F2N8O4 - PubChem. [online] Pubchem.ncbi.nlm.nih.gov. Available at: http://pubchem.ncbi.nlm.nih.gov/compound/Posaconazole [Accessed 21 Apr. 2015].

In-text: (Sambrook, 2014)

Your Bibliography: Sambrook, D. (2014). Candidiasis | Doctor | Patient.co.uk. [online] Patient.co.uk. Available at: http://www.patient.co.uk/doctor/candidiasis [Accessed 11 Apr. 2015].

In-text: (Shalmali, 2015)

Your Bibliography: Shalmali, R. (2015). Advantages and Disadvantages of Pharmaceutical Suspension. [online] Preservearticles.com. Available at: http://www.preservearticles.com/2011091513442/advantages-and-disadvantages-of-pharmaceutical-suspension.html [Accessed 21 Apr. 2015].

In-text: (UNC, n.d.)

Your Bibliography: UNC (n.d.). The Pharmaceutics and Compounding Laboratory. [online] Pharmlabs.unc.edu. Available at: http://pharmlabs.unc.edu/labs/suspensions/suspensions.htm [Accessed 22 Apr. 2015].

In-text: (United States National Library of Medicine, 2015)

Your Bibliography: United States National Library of Medicine (2015). DailyMed - NOXAFIL- posaconazole suspension NOXAFIL- posaconazole tablet, coated NOXAFIL- posaconazole solution. [online] Dailymed.nlm.nih.gov. Available at: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b073b082-7b57-4423-8c06-4fd4263d6f84#S12.4 [Accessed 18 Apr. 2015].

In-text: (Whiteway and Bachewich, 2007)

Your Bibliography: Whiteway, M. and Bachewich, C. (2007). Morphogenesis in Candida albicans *. Annu. Rev. Microbiol., [online] 61(1), p.530. Available at: http://spectrum.library.concordia.ca/7580/1/Bachewich_ARM2007.pdf [Accessed 24 Apr. 2015].

In-text: (Zonios and Bennett, 2008)

Your Bibliography: Zonios, D. and Bennett, J. (2008). Update on Azole Antifungals. Seminars in Respiratory and Critical Care Medicine, 29(2).